category

Earnings Report

Under Armour Shares Slump on Earnings Miss

Sportswear maker Under Armour Inc reported lower-than-expected quarterly profit and revenue, hurt by stiff competition and slowing growth in North America, and the company's shares plunged before the bell.

Under Armour Shares Slump on Earnings Miss

Sportswear maker Under Armour Inc reported lower-than-expected quarterly profit and revenue, hurt by stiff competition and slowing growth in North America, and the company's shares plunged before the bell.

Pfizer Quarterly Profit Misses Estimates

Pfizer, which closed its $14 billion acquisition of Medivation in September, reported a lower-than-expected profit, hit by lower demand for products set to go off patent.

Pfizer Quarterly Profit Misses Estimates

Pfizer, which closed its $14 billion acquisition of Medivation in September, reported a lower-than-expected profit, hit by lower demand for products set to go off patent.

United Parcel's 4Q Results Fall Short

United Parcel reported an adjusted 4Q profit of $1.63 per share, missing the estimate for $1.69. Revenue for the package delivery company came in at $16.93 billion. The estimate was for $17 billion.

United Parcel's 4Q Results Fall Short

United Parcel reported an adjusted 4Q profit of $1.63 per share, missing the estimate for $1.69. Revenue for the package delivery company came in at $16.93 billion. The estimate was for $17 billion.

Sprint Posts Wider Than Expected 3Q Loss

Sprint reported a 3Q loss of $0.12 per share, coming in larger than the estimate for a loss of $0.09. Revenue for the company came in at $8.55 billion, beating the estimate for $8.28 billion.

Sprint Posts Wider Than Expected 3Q Loss

Sprint reported a 3Q loss of $0.12 per share, coming in larger than the estimate for a loss of $0.09. Revenue for the company came in at $8.55 billion, beating the estimate for $8.28 billion.

Pfizer 4Q Profit Misses Estimates

Pfizer, which closed its $14 billion acquisition of Medivation in September, reported a lower-than-expected profit, hit by lower demand for products set to go off patent.